Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403111 | 12540311 | 1 | I | 2004 | 20150807 | 20160708 | 20160708 | PER | US-DSJP-DSU-2015-125001 | DAIICHI | 0.00 | M | Y | 88.44000 | KG | 20160708 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403111 | 12540311 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40-25MG, ONCE DAILY | Y | 21532 | FILM-COATED TABLET | ||||||||
| 125403111 | 12540311 | 2 | C | CARVEDILOL. | CARVEDILOL | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 125403111 | 12540311 | 3 | C | CARVEDILOL. | CARVEDILOL | 1 | 80 MG, UNK | 0 | 80 | MG | |||||||||
| 125403111 | 12540311 | 4 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 125403111 | 12540311 | 5 | C | DILTIAZEM. | DILTIAZEM | 1 | 120 MG, UNK | 0 | 120 | MG | |||||||||
| 125403111 | 12540311 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 125403111 | 12540311 | 7 | C | VALSARTAN. | VALSARTAN | 1 | 100MG/12.5MG, UNK | 0 | |||||||||||
| 125403111 | 12540311 | 8 | C | ELIQUIS | APIXABAN | 1 | 5 MG, QD | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125403111 | 12540311 | 1 | Hypertension |
| 125403111 | 12540311 | 2 | Product used for unknown indication |
| 125403111 | 12540311 | 4 | Product used for unknown indication |
| 125403111 | 12540311 | 5 | Product used for unknown indication |
| 125403111 | 12540311 | 6 | Product used for unknown indication |
| 125403111 | 12540311 | 7 | Product used for unknown indication |
| 125403111 | 12540311 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125403111 | 12540311 | Diverticulum | |
| 125403111 | 12540311 | Gastrointestinal haemorrhage | |
| 125403111 | 12540311 | Large intestine polyp | |
| 125403111 | 12540311 | Malabsorption | |
| 125403111 | 12540311 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125403111 | 12540311 | 1 | 2004 | 201503 | 0 | |
| 125403111 | 12540311 | 2 | 2005 | 0 | ||
| 125403111 | 12540311 | 3 | 2005 | 0 | ||
| 125403111 | 12540311 | 4 | 2009 | 2014 | 0 | |
| 125403111 | 12540311 | 5 | 2013 | 2013 | 0 | |
| 125403111 | 12540311 | 6 | 2013 | 2013 | 0 | |
| 125403111 | 12540311 | 7 | 2004 | 2004 | 0 |